| Long name | CD69 Primary Polyclonal Antibody |
| Also known as | CD69 PAb |
| Category | Primary Antibodies |
| Conjugation | Unconjugated |
| Target Antigen | CD69/CLEC2C/AIM |
| Specificity | This is a highly specific antibody against CD69/CLEC2C/AIM |
| Modification(s) | None |
| Modification site(s) | Unmodified antibody |
| Clonality | Polyclonal antibody |
| Clone number | Polyclonal antibody |
| Concentration | 1ug per 1ul |
| Immunogen range | 100-150/199 |
| Subcellular location | Extracellular |
| Source | This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human CD69 |
| Gene ID number | 969 |
| Swiss Prot | Q07108 |
| Tested Applications | IF(IHC-P), IHC-P, WB |
| Recommended dilutions | IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity | Mouse, Rat, Human |
| Cross reactive species details | not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen | and platelets, natural killer (NK) cells, Involved in lymphocyte proliferation and functions as a signal transmitting receptor in lymphocytes |
| Purification method | This antibody was purified via Protein A |
| Storage conditions | 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names | Activation inducer molecule, BL-AC/P26, C-type lectin domain family 2 member C, CD69, CLEC2C, EA1, Early T-cell activation antigen p6, Early activation antigen CD69, GP32/28, Leukocyte surface antigen Leu-23, MLR-3, AIM |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target | CD69 |
| Short name | CD69 Antibody |
| Technique | antibodies against human proteins, antibodies for, Antibody |
| Alternative name | CD69 molecule (Antibody to) |
| Alternative technique | antibodies |
| Alternative to gene target | AIM and BL-AC/P26 and CLEC2C and EA1 and GP32/28 and MLR-3, CD69 and IDBG-18077 and ENSG00000110848 and 969, CD69 and IDBG-639618 and ENSBTAG00000002135 and 281058, Cd69 and IDBG-191849 and ENSMUSG00000030156 and 12515, Cell surfaces, carbohydrate binding, this GO :0004888 and transmembrane signaling receptor activity and molecular function this GO :0005509 and calcium ion binding and molecular function this GO :0005887 and integral component of plasma membrane and cellular component this GO :0007165 and signal transduction and biological process this GO :0009897 and external side of plasma membrane and cellular component this GO :0030246 and carbohydrate binding and molecular function this GO :0035690 and cellular response to drug and biological process, this GO :0004888: transmembrane signaling receptor activity, this GO :0004888: transmembrane signaling receptor activity and also this GO :0005509: calcium ion binding and also this GO :0030246: carbohydrate binding, this GO :0005509: calcium ion binding, this GO :0030246: carbohydrate binding, CD69 molecule |
| Identity | 1694 |
| Gene | CD69 |
| Long gene name | CD69 molecule |
| Synonyms gene name | CD69 antigen (p60, early T-cell activation antigen) |
| Synonyms | CLEC2C |
| Locus | 12p13, 31 |
| Discovery year | 1992-08-06 |
| GenBank acession | Z22576 |
| Entrez gene record | 969 |
| Pubmed identfication | 1612643 |
| Classification | CD molecules C-type lectin domain family |
| Havana BLAST/BLAT | OTTHUMG00000168481 |